Vascular Intervention Devices
•30 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (30)
| Company | Market Cap | Price |
|---|---|---|
|
JNJ
Johnson & Johnson
Shockwave Medical IVL and related vascular interventions place J&J in vascular intervention devices.
|
$454.86B |
$188.88
-0.09%
|
|
ABT
Abbott Laboratories
Intravascular lithotripsy and other vascular/interventional devices underpin Abbott's structural/vascular therapies.
|
$215.16B |
$123.64
-0.83%
|
|
BSX
Boston Scientific Corporation
Endovascular/vascular intervention devices including balloons, stents, IVL, and related intravascular therapies.
|
$149.01B |
$100.73
+0.16%
|
|
SYK
Stryker Corporation
Inari Medical peripheral vascular thrombectomy devices place in vascular intervention category.
|
$136.19B |
$355.94
-3.53%
|
|
MDT
Medtronic plc
PFA and other catheter/ablation technologies fit within Vascular Intervention Devices.
|
$116.21B |
$90.71
-0.29%
|
|
EW
Edwards Lifesciences Corporation
Includes transcatheter repair and replacement devices (Pascal, Evoque, SAPIEN M3) used in vascular/interventional therapies.
|
$48.37B |
$82.41
-1.28%
|
|
PEN
Penumbra, Inc.
Penumbra's core offerings include vascular intervention devices used for thrombectomy and catheter-based clot removal.
|
$8.81B |
$227.64
-1.68%
|
|
TFX
Teleflex Incorporated
Core vascular intervention devices such as balloons, stents, and scaffolds from BIOTRONIK Vascular Intervention portfolio are direct Teleflex offerings.
|
$5.50B |
$124.49
-0.28%
|
|
MMSI
Merit Medical Systems, Inc.
Vascular/interventional devices focus, including WRAPSODY endoprosthesis for dialysis access.
|
$5.18B |
$87.48
+5.35%
|
|
LIVN
LivaNova PLC
Vascular Intervention Devices capturing their endovascular cannulae components used in ECMO and related procedures.
|
$2.87B |
$52.65
-0.27%
|
|
HAE
Haemonetics Corporation
VASCADE MVP/XL vascular intervention devices are core interventional technologies the company sells.
|
$2.40B |
$50.00
+0.02%
|
|
ITGR
Integer Holdings Corporation
Vascular intervention devices are part of Integer's served markets (e.g., neurovascular), warranting inclusion as a sales/production category.
|
$2.26B |
$64.53
+1.91%
|
|
LMAT
LeMaitre Vascular, Inc.
Directly produces vascular interventional devices (grafts, patches, shunts, catheters) used in vascular surgery.
|
$1.96B |
$86.53
-2.28%
|
|
AORT
Artivion, Inc.
Covers vascular/interventional devices (AMDS, NEXUS, Arcevo LSA) used in complex aortic repair.
|
$1.94B |
$45.38
-0.59%
|
|
ANGO
AngioDynamics, Inc.
Core product category: vascular intervention devices, including Auryon, AlphaVac, and AngioVac.
|
$488.83M |
$12.04
-0.86%
|
|
SRDX
Surmodics, Inc.
Surmodics' vascular intervention devices (SurVeil DCB, Pounce thrombectomy, Sublime radial access) are a core product category sold by the company.
|
$392.30M |
$27.49
+1.18%
|
|
DCTH
Delcath Systems, Inc.
The hepatic delivery approach relies on vascular/interventional devices to isolate hepatic circulation during treatment.
|
$342.34M |
$9.82
+4.52%
|
|
HUMA
Humacyte, Inc.
Humacyte's Symvess is a vascular conduit/endovascular device used for extremity vascular trauma—fits Vascular Intervention Devices.
|
$259.05M |
$1.66
+2.47%
|
|
STXS
Stereotaxis, Inc.
Vascular intervention catheters and devices (e.g., EMAGIN) place STXS in the vascular/endovascular products space.
|
$250.26M |
$2.90
-0.86%
|
|
TLSI
TriSalus Life Sciences, Inc.
TriNav and related systems are vascular intervention devices used for embolization and targeted drug delivery.
|
$179.36M |
$4.72
+1.07%
|
|
AVR
Anteris Technologies Global Corp.
Ends in vascular/cardiovascular interventions; the DurAVR valve is delivered via a balloon-expandable system, classifying as vascular intervention devices.
|
$161.92M |
$4.50
+4.29%
|
|
OBIO
Orchestra BioMed Holdings, Inc.
Virtue SAB is a drug-delivery balloon device for vascular interventions (coronary/peripheral).
|
$149.42M |
$3.89
-2.99%
|
|
MBOT
Microbot Medical Inc.
LIBERTY functions as a vascular/interventional device for endovascular surgery, aligning with Vascular Intervention Devices.
|
$81.12M |
$2.23
+3.01%
|
|
NSPR
InspireMD, Inc.
InspireMD's core products are vascular/interventional endovascular devices (carotid stent systems with embolic protection).
|
$67.70M |
$2.21
+0.91%
|
|
ELUT
Elutia Inc.
CV portfolio includes vascular/interventional device applications related to the company’s products (e.g., pericardial/vascular use cases).
|
$37.39M |
$0.90
-0.69%
|
|
NVNO
enVVeno Medical Corporation
The VenoValve is a surgically implanted vascular intervention device, directly produced by NVNO.
|
$13.57M |
$0.70
+0.22%
|
|
PAVM
PAVmed Inc.
PortIO intraosseous vascular access device is a core implantable medical device product.
|
$7.56M |
$0.43
+0.62%
|
|
AMIX
Autonomix Medical, Inc. Common Stock
Platform is vascular-intervention/ endovascular in nature, delivered via the bloodstream to target neural structures.
|
$2.86M |
$1.02
-0.97%
|
|
VTAK
Catheter Precision, Inc.
Assets related to pericardial access and interventional concepts align with Vascular Intervention Devices.
|
$1.42M |
$2.45
+2.08%
|
|
NAOV
NanoVibronix, Inc.
ENvue supports vascular access procedures, aligning with Vascular Intervention Devices.
|
$1.33M |
$5.09
-4.14%
|
Loading company comparison...
Loading industry trends...
Loading research report...
